This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2016 Remove Dosage Remove Process Improvement Related Topics
Packaging Compounding Communication Documentation FDA Vaccines Health and Personal Care Stores Hospitals More Related Topics >
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

SEPTEMBER 11, 2023

POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. 12 April 2016. Pharmaceutical Processing World. Developing the Biofacility of the Future Based on Continuous Processing and Single-Use Technology.” BioProcess International 14 (2016):38–43. October 2022.

Health and Personal Care Stores 52
Health and Personal Care Stores Vaccines Packaging Documentation 52
article thumbnail

Oligonucleotides: A Cornerstone for Therapeutics & More

ISPE

OCTOBER 27, 2022

Since 2016, drug approvals per clinical campaign have outpaced the average across all modalities, resulting in 11 FDA-approved therapies in that span. 5’-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates.” 11 (2 June 2016): 985–89. Brigham, et al. “5’-(E)-Vinylphosphonate:

Process Improvement 98
Process Improvement Packaging Dosage Compounding 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024